Año: 2017
Journal Impact Factor (JIF): 4,952
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PERIPHERAL VASCULAR DISEASE | SCIE | 6/65 | Q1 | T1 | D1 |
| HEMATOLOGY | SCIE | 13/71 | Q1 | T1 | D2 |
Año: 2017
Journal Citation Indicator (JCI): 1,250
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| HEMATOLOGY | 12/87 | Q1 | T1 | D2 | 86,78 |
| PERIPHERAL VASCULAR DISEASE | 6/82 | Q1 | T1 | D1 | 93,29 |
Año:
2017
CiteScore:
8,500
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Hematology | 10/123 | Q1 | T1 | D1 |
SJR año:
2017
Factor de Impacto:
2,074
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Hematology | 16/127 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Novo Nordisk NS (Bagsvaerd, Denmark) | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | University of Oxford (England) | |
| 2 | Andreeva, T | St Petersburg Hemophilia Ctr (Russia) |
| 3 | Chowdary, P | UCL Medical School (England) |
| 4 | Ehrenforth, S | Novo Nordisk (Denmark) |
| 5 | Hanabusa, H | Ogikubo Hosp (Japan) |
| 6 | Leebeek, FWG | Erasmus MC (Netherlands) |
| 7 | Lentz, SR | University of Iowa (USA) |
| 8 | Nemes, L | State Hlth Ctr (Hungary) |
| 9 | Poulsen, LH | Aarhus University (Denmark) |
| 10 | Santagostino, E | IRCCS Ca Granda Ospedale Maggiore Policlinico (Italy) |
| 11 | You, CW | Eulji University (South Korea) |
| 12 | Clausen, WHO | Novo Nordisk (Denmark) |
| 13 | Jonsson, PG | Novo Nordisk (Denmark) |
| 14 | Oldenburg, J | University Hospital Bonn Institute for Experimental Hematology and Transfusion Medicine (Germany) |
| # | Autoría grupal | Afiliación |
| 1 | Pathfinder Investigators | Sin datos () |
| 2 | Mingot, E.M. (Pathfinder Investigators) | Sin datos () |
